Cerephex to seek FDA clearance for fibromyalgia treatment

06/3/2010 | Medical Devices Today

Cerephex said it will submit an application with the FDA within a year to seek 510(k) clearance for NeuroPoint, a non-invasive device that delivers cortical stimulation to treat fibromyalgia. The company plans to schedule a July meeting with the agency to ask for comments on its two-year study data.

View Full Article in:

Medical Devices Today

Published in Brief:

SmartBrief Job Listings for Health Care